Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Historic Deal Positions FIA World Endurance Championship for Record Decade of Growth as the Sport Enters its Golden Age
-
All rivers converge, creating an endless stream of sound | “Hearing Each Other” 2026 World Rivers Gala is about to begin.
-
Kalmar wins preventive and corrective maintenance contract for STS and ASC cranes at TTI Algeciras
-
Change in number of shares and votes in Sobi
-
Tonner Drones publishes its semi-annual results 2026
-
Orion Corporation completed share acquisitions
-
ICG Silver & Gold Intersects 24.3 Meters of 10.14 g/t Gold, Including 4.6 Meters of 51.84 g/t Gold and 10.2 g/t Silver, at the Tuscarora District, Nevada
-
Klarvant Expands Namespace Command With Automation and Machine-to-Machine Access for AI Systems
-
Orosur Mining Inc: Total Voting Rights
-
Alpha Growth Management Opens Rep Office in Japan
-
Q1 Trading Statement 2026/27: Bang & Olufsen generated revenue growth of 2.2% in local currencies
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 30
-
Juicebox Opens London Office as UK and EMEA Companies Rethink How They Hire
-
Alpha Longevity Management Rebrands as Alpha Growth Management (Bermuda) Ltd; Establishes Representative Office in Japan
-
Sun Mountain Partners, a Shareholder of Ashtead Technology, Urges the Board to Reject Ember’s 615p Proposal
-
The Board of Directors of IQM Quantum Computers Plc has resolved to establish new share-based long-term incentive plans for the employees of the group
-
Haffner Energy will market the hydrogen produced at Marolles via an HRS station
-
AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness
-
NBPE Announces Transaction in Own Shares
-
Commencement of Share Buyback Programme
-
Transaction in Own Shares
-
Orion Corporation: Acquisition of own shares during week 40, 2026
-
Total Voting Rights
-
Guardian Metal Resources PLC Announces Total Voting Rights
-
Breaking the Safety Barrier: Insilico Medicine Nominates ISM1354, the Next-Generation Small Molecule GIPR Antagonist
-
Tetragon Financial Group Limited August 2026 Monthly Factsheet
-
Smart, Secure and Scalable: Flatworld Mortgage Reimagines Mortgage Operations
-
Apeing Raises the Stakes: 281,538,380 Tokens Burned as Apeing Enters the Next Crypto to Explode Conversation With Bitcoin and BNB in Focus
-
AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026
-
TomTom brings location intelligence to Microsoft Fabric
-
CIO Launches SmartCoby Ultra Slim SS5K on Kickstarter, Building on Ultra Slim 3K's Breakout Crowdfunding Success
-
Thomas Roofing and Repair Named Among Top Roofing Contractors in Orlando, FL by ThreeBestRated
-
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
-
Kodiact Introduces the First Intelligent Simulation Platform for Direct Materials
-
Fall Wardrobe Quality Upgrade: COOFANDY Unveils Early Fall Menswear Preview
-
Pro-Grade AI Diagnosis, Without the Pro-Grade Price: THINKSCAN 689BT PRO Brings 610 Racing’s Know-How to the DIYer
-
One Payment Plan Sees Comparison, Education, and Consumer Choice Shaping the Future of Debt Relief
-
McLarty Nissan of Little Rock Highlights Used Vehicles Priced Below $15,000 In Little Rock Arkansas
-
VDURA Data Platform V12 Now Generally Available, the Hyperscaler Storage Playbook to AI Factories and Neoclouds on Supermicro
-
59/2026・Trifork Group AG initiates cancellation of 2.5% of its share capital
-
Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026
-
Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosis
-
Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill
-
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis
-
Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg Expansion in Healthy Volunteer Study
-
Roche launches newborn screening test for three severe genetic conditions
-
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
-
Greta Garbo is back - starring in SKF's initiative to overcome friction
-
Navigator Medicines Presents New Data at EADV 2026 as Bispecific Antibody Program Advances at Speed in Hidradenitis Suppurativa
-
Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis
